Variant report
Variant | nsv890886 |
---|---|
Chromosome Location | chr8:51802055-51946827 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:167)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ATF2 | chr8:51934062-51934395 | GM12878 | blood: | n/a | n/a |
2 | BATF | chr8:51934082-51934330 | GM12878 | blood: | n/a | chr8:51934250-51934261 |
3 | BATF | chr8:51934115-51934341 | GM12878 | blood: | n/a | chr8:51934250-51934261 |
4 | BCL11A | chr8:51934103-51934327 | GM12878 | blood: | n/a | n/a |
5 | CEBPB | chr8:51815008-51815301 | Hela-S3 | cervix: | n/a | chr8:51815099-51815110 |
6 | CEBPB | chr8:51943318-51943587 | IMR90 | lung: | n/a | n/a |
7 | CEBPB | chr8:51853777-51854033 | A549 | lung: | n/a | n/a |
8 | CEBPB | chr8:51853747-51854039 | IMR90 | lung: | n/a | n/a |
9 | CEBPB | chr8:51943286-51943588 | HepG2 | liver: | n/a | n/a |
10 | CEBPB | chr8:51815003-51815238 | HepG2 | liver: | n/a | chr8:51815099-51815110 |
11 | CEBPB | chr8:51853745-51854060 | H1-hESC | embryonic stem cell: | n/a | n/a |
12 | CTCF | chr8:51885340-51885490 | Caco-2 | colon: | n/a | n/a |
13 | CTCF | chr8:51810680-51810830 | HPF | lung: | n/a | n/a |
14 | CTCF | chr8:51810691-51810820 | MCF-7 | breast: | n/a | n/a |
15 | CTCF | chr8:51913389-51913420 | GM10266 | blood: | n/a | n/a |
16 | CTCF | chr8:51810620-51810770 | HEEpiC | esophagus: | n/a | n/a |
17 | CTCF | chr8:51810682-51810839 | MCF-7 | breast: | n/a | n/a |
18 | CTCF | chr8:51860171-51860176 | LNCaP | prostate: | n/a | n/a |
19 | CTCF | chr8:51856871-51856889 | MCF-7 | breast: | n/a | n/a |
20 | CTCF | chr8:51810696-51810845 | MCF-7 | breast: | n/a | n/a |
21 | CTCF | chr8:51856980-51857130 | MCF-7 | breast: | n/a | n/a |
22 | CTCF | chr8:51856671-51856989 | T-47D | breast: | n/a | n/a |
23 | CTCF | chr8:51810660-51810810 | MCF-7 | breast: | n/a | n/a |
24 | CTCF | chr8:51810686-51810812 | MCF-7 | breast: | n/a | n/a |
25 | CTCF | chr8:51856872-51856953 | LNCaP | prostate: | n/a | n/a |
26 | CTCF | chr8:51810680-51810850 | MCF-7 | breast: | n/a | n/a |
27 | CTCF | chr8:51810720-51810870 | Caco-2 | colon: | n/a | n/a |
28 | CTCF | chr8:51865763-51865828 | GM10266 | blood: | n/a | n/a |
29 | CTCF | chr8:51810720-51810870 | HPF | lung: | n/a | n/a |
30 | CTCF | chr8:51940220-51940245 | Lung_OC | lung: | n/a | n/a |
31 | CTCF | chr8:51832477-51832604 | Spleen_OC | spleen: | n/a | n/a |
32 | CTCF | chr8:51810500-51810650 | Hela-S3 | cervix: | n/a | n/a |
33 | CTCF | chr8:51901176-51901215 | GM20000 | blood: | n/a | n/a |
34 | E2F4 | chr8:51937201-51937571 | MCF10A-Er-Src | breast: | n/a | n/a |
35 | E2F4 | chr8:51842582-51842805 | MCF10A-Er-Src | breast: | n/a | n/a |
36 | E2F4 | chr8:51808436-51808664 | MCF10A-Er-Src | breast: | n/a | n/a |
37 | E2F4 | chr8:51893910-51894441 | MCF10A-Er-Src | breast: | n/a | n/a |
38 | E2F4 | chr8:51918023-51918214 | MCF10A-Er-Src | breast: | n/a | n/a |
39 | E2F4 | chr8:51895598-51895784 | MCF10A-Er-Src | breast: | n/a | n/a |
40 | E2F4 | chr8:51919099-51919441 | MCF10A-Er-Src | breast: | n/a | n/a |
41 | EBF1 | chr8:51932957-51933099 | GM12878 | blood: | n/a | n/a |
42 | EBF1 | chr8:51933670-51934344 | GM12878 | blood: | n/a | n/a |
43 | EP300 | chr8:51934134-51934362 | GM12878 | blood: | n/a | n/a |
44 | EP300 | chr8:51933587-51933907 | GM12878 | blood: | n/a | n/a |
45 | EP300 | chr8:51934100-51934384 | GM12878 | blood: | n/a | n/a |
46 | FAM48A | chr8:51834461-51834598 | GM12878 | blood: | n/a | n/a |
47 | FAM48A | chr8:51805226-51805280 | GM12878 | blood: | n/a | n/a |
48 | FAM48A | chr8:51879216-51879319 | GM12878 | blood: | n/a | n/a |
49 | FOS | chr8:51842970-51843253 | MCF10A-Er-Src | breast: | n/a | n/a |
50 | FOS | chr8:51841960-51842306 | MCF10A-Er-Src | breast: | n/a | n/a |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000201316 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs183187146 | chr8:51807234-51807235 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs370858948 | chr8:51807277-51807278 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs553836247 | chr8:51807351-51807352 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs572084609 | chr8:51807413-51807414 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs546091023 | chr8:51807430-51807431 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs564374144 | chr8:51807444-51807445 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs13268743 | chr8:51807451-51807452 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs10088818 | chr8:51807454-51807455 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs562997419 | chr8:51807465-51807466 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs530164689 | chr8:51807491-51807492 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs548163960 | chr8:51807530-51807531 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs187619587 | chr8:51807552-51807553 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs72647180 | chr8:51807591-51807592 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs141539864 | chr8:51807592-51807593 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs150882078 | chr8:51807634-51807635 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs538427527 | chr8:51807645-51807646 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs199904639 | chr8:51807647-51807648 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs556506551 | chr8:51807660-51807661 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs17787699 | chr8:51807663-51807664 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs73574081 | chr8:51807702-51807703 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs553925853 | chr8:51807785-51807786 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs566058950 | chr8:51807792-51807793 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs370442810 | chr8:51807824-51807825 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs192602164 | chr8:51807826-51807827 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs545823505 | chr8:51807866-51807867 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs183473305 | chr8:51807907-51807908 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs144507320 | chr8:51807976-51807977 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs543583658 | chr8:51808056-51808057 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs189505578 | chr8:51808091-51808092 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs529071786 | chr8:51808121-51808122 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs554009993 | chr8:51808140-51808141 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs541894209 | chr8:51808175-51808176 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs570617757 | chr8:51808187-51808188 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs192688768 | chr8:51808212-51808213 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs184986764 | chr8:51808216-51808217 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs552196403 | chr8:51808223-51808224 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs189917366 | chr8:51808258-51808259 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs74631992 | chr8:51808265-51808266 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs373726304 | chr8:51808269-51808270 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs74768266 | chr8:51808325-51808326 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs568532213 | chr8:51808328-51808329 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs117470764 | chr8:51808390-51808391 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs181487430 | chr8:51808394-51808395 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs565821944 | chr8:51808430-51808431 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs539438942 | chr8:51808510-51808511 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs536511106 | chr8:51808531-51808532 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs186175757 | chr8:51808551-51808552 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs35944831 | chr8:51808555-51808556 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs77172442 | chr8:51808558-51808559 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs536915326 | chr8:51808575-51808576 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Developmental delay | 21373258 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 20164920 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Melanoma | 17363583 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
22q11 deletion syndrome | 20357662 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:51807200-51808000 | Enhancers | Fetal Brain Male | brain |
2 | chr8:51807600-51810600 | Weak transcription | Fetal Lung | lung |
3 | chr8:51810400-51810800 | ZNF genes & repeats | Pancreas | Pancrea |
4 | chr8:51810600-51811000 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
5 | chr8:51810600-51811800 | Enhancers | Fetal Lung | lung |
6 | chr8:51811000-51811600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
7 | chr8:51811800-51816400 | Weak transcription | Fetal Lung | lung |
8 | chr8:51816400-51817400 | Enhancers | Fetal Lung | lung |
9 | chr8:51823400-51823600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
10 | chr8:51823600-51824200 | Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
11 | chr8:51823600-51824200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
12 | chr8:51824200-51825000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
13 | chr8:51834200-51836800 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
14 | chr8:51836200-51836600 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
15 | chr8:51842200-51842800 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
16 | chr8:51846800-51847200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
17 | chr8:51857000-51859400 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
18 | chr8:51885000-51885400 | Enhancers | Cortex derived primary cultured neurospheres | brain |
19 | chr8:51885200-51886000 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
20 | chr8:51897800-51899000 | Enhancers | Dnd41 | blood |
21 | chr8:51932000-51932200 | Active TSS | ES-UCSF4 Cell Line | embryonic stem cell |
22 | chr8:51933200-51933400 | Active TSS | GM12878-XiMat | blood |
23 | chr8:51933400-51933600 | Flanking Active TSS | GM12878-XiMat | blood |
24 | chr8:51933600-51933800 | ZNF genes & repeats | GM12878-XiMat | blood |
25 | chr8:51933600-51934200 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
26 | chr8:51933800-51934000 | Flanking Active TSS | GM12878-XiMat | blood |
27 | chr8:51944600-51945000 | Enhancers | Adipose Nuclei | Adipose |